Near Miss or Standard of Care? <i>DPYD</i> Screening for Cancer Patients Receiving Fluorouracil

5-fluorouracil (5-FU) and its pro-drug capecitabine are widely used anticancer agents. Most 5-FU catabolism is dependent on dihydropyrimidine dehydrogenase (DPD) encoded by the <i>DPYD</i> gene, and <i>DPYD</i> variants that reduce DPD function increase 5-FU toxicity. Most DPD deficient patients are...

Descripción completa

Detalles Bibliográficos

Autores principales:	Lauren E. Winquist, Michael Sanatani, Richard B. Kim, Eric Winquist
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2020-12-01
Colección:	Current Oncology
Materias:	fluoropyrimidines dihydropyrimidine dehydrogenase cancer adverse effects single nucleotide polymorphisms drug therapy
Acceso en línea:	https://www.mdpi.com/1718-7729/28/1/12
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!